125 studies found for:    "Choroiditis"
Show Display Options
Rank Status Study
1 Recruiting Safety, Tolerability and Efficacy of Intravitreal LFG316 in Patients With Multifocal Choroiditis and Panuveitis (MCP)
Conditions: Multifocal Choroiditis;   Panuveitis;   Active Vitritis
Interventions: Drug: LFG316;   Drug: Conventional Therapy
2 Completed Intravitreal Bevacizumab for Inflammatory Neovascular Membranes
Conditions: Vogt Koyanagi Harada Disease;   Serpiginous Choroiditis;   Multifocal Choroiditis
Interventions: Drug: Bevacizumab;   Procedure: Intravitreal Injection of Bevacizumab
3 Completed Evaluation and Treatment of Patients With Inflammatory Eye Diseases
Conditions: Choroiditis;   Iridocyclitis;   Iritis;   Retinal Disease
Intervention:
4 Completed Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization
Conditions: Neovascularization;   Tuberculosis;   Multifocal Serpiginous Choroiditis;   Harada Toxoplasmosis
Intervention:
5 Withdrawn Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD
Conditions: Choroidal Neovascularization;   Myopia;   Punctate Inner Choroidopathy (PIC);   Multifocal Choroiditis;   Ocular Histoplasmosis Syndrome;   Central Serous Chorioretinopathy (CSC);   Angioid Streaks;   Trauma, or Hereditary Eye Diseases
Interventions: Drug: Bevacizumab (Avastin; Genentech, Inc.);   Drug: Bevacizumab, Dexamethasone, Verteporfin Photodynamic Therapy
6 Completed Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy
Conditions: Coats' Disease;   Idiopathic Retinal Telangiectasia;   Retinal Angiomatous Proliferation;   Polypoidal Choroidal Vasculopathy;   Pseudoxanthoma Elasticum;   Pathological Myopia;   Multi-focal Choroiditis;   Rubeosis Iridis;   Von Hippel Lindau Disease;   BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL (Disorder)
Intervention: Drug: ranibizumab injection (0.5 mg)
7 Completed Safety and Efficacy of AIN457 in Noninfectious Uveitis
Condition: Active Uveitis That is Not From an Infection.
Interventions: Drug: AIN457 subcutaneous dose;   Drug: AIN457 low dose (i.v);   Drug: AIN457 high dose (i.v)
8 Completed
Has Results
Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment
Condition: Uveitis
Intervention: Drug: 0.59 mg Fluocinolone Acetonide implant
9 Completed Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
Condition: Anterior Uveitis
Intervention: Drug: Difluprednate Ophthalmic Emulsion
10 Terminated A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis
Condition: Anterior Uveitis
Intervention: Drug: Dexamethasone
11 Recruiting Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation
Conditions: Inflammation;   Pain;   Cataract
Interventions: Drug: XG-102;   Drug: Placebo
12 Enrolling by invitation Clinical Outcome in Uveitis
Condition: Uveitis
Intervention:
13 Completed Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis
Condition: Anterior Uveitis
Interventions: Drug: 40 mg/mL Dexamethasone phosphate ophthalmic solution;   Drug: Prednisolone Acetate (1%) Eyedrops;   Drug: 100 mM sodium citrate buffer solution;   Drug: Placebo Eyedrops
14 Completed Influencing Factors in Uveitis
Condition: Uveitis
Intervention:
15 Unknown  Uveitis in Relation to Perceived Stress: A Prospective Study
Condition: Uveitis
Intervention:
16 Recruiting Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
Conditions: Posterior Uveitis;   Intermediate Uveitis;   Panuveitis
Interventions: Drug: FAI insert;   Drug: Sham injection
17 Unknown  Acute Anterior Uveitis: Psychic Burden and Pain
Condition: Anterior Uveitis
Intervention: Other: Filling in a patient questionnaire
18 Completed A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis
Conditions: Uveitis, Anterior;   Panuveitis
Interventions: Drug: Placebo;   Drug: LX211
19 Recruiting Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
Condition: Uveitis
Interventions: Drug: Sarilumab SAR153191/REGN88;   Drug: Prednisone;   Drug: Methotrexate;   Drug: Folic/folinic acid;   Other: Sarilumab (SAR153191/REGN88) placebo
20 Completed Optiquel as Corticosteroid-sparing Therapy for Chronic Noninfectious Uveitis
Condition: Uveitis
Intervention: Drug: Peptide B27PD

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years